Literature DB >> 17083960

Structural and thermodynamic studies of simple aldose reductase-inhibitor complexes.

June M Brownlee1, Erik Carlson, Amy C Milne, Erika Pape, David H T Harrison.   

Abstract

The competitive inhibition constants of series of inhibitors related to phenylacetic acid against both wild-type and the doubly mutanted C298A/W219Y aldose reductase have been measured. Van't Hoff analysis shows that these acids bind with an enthalpy near -6.8 kcal/mol derived from the electrostatic interactions, while the 100-fold differences in binding affinity appear to be largely due to entropic factors that result from differences in conformational freedom in the unbound state. These temperature studies also point out the difference between substrate and inhibitor binding. X-ray crystallographic analysis of a few of these inhibitor complexes both confirms the importance of a previously described anion binding site and reveals the hydrophobic nature of the primary binding site and its general plasticity. Based on these results, N-glycylthiosuccinimides were synthesized to demonstrate their potential in studies that probe distal binding sites. Reduced alpha-lipoic acid, an anti-oxidant and therapeutic for diabetic complications, was shown to bind aldose reductase with a binding constant of 1 microM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083960      PMCID: PMC1815394          DOI: 10.1016/j.bioorg.2006.09.004

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  33 in total

1.  Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.

Authors:  K J Ruhnau; H P Meissner; J R Finn; M Reljanovic; M Lobisch; K Schütte; D Nehrdich; H J Tritschler; H Mehnert; D Ziegler
Journal:  Diabet Med       Date:  1999-12       Impact factor: 4.359

2.  Comparison of hydrogen determination with X-ray and neutron crystallography in a human aldose reductase-inhibitor complex.

Authors:  M P Blakeley; A Mitschler; I Hazemann; F Meilleur; D A A Myles; A Podjarny
Journal:  Eur Biophys J       Date:  2006-04-19       Impact factor: 1.733

Review 3.  Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets.

Authors:  Hiroyasu Ohtaka; Salman Muzammil; Arne Schön; Adrian Velazquez-Campoy; Sonia Vega; Ernesto Freire
Journal:  Int J Biochem Cell Biol       Date:  2004-09       Impact factor: 5.085

Review 4.  Hyperglycemia, polyol metabolism, and complications of diabetes mellitus.

Authors:  K H Gabbay
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

5.  Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

Authors:  N Hotta; T Toyota; K Matsuoka; Y Shigeta; R Kikkawa; T Kaneko; A Takahashi; K Sugimura; Y Koike; J Ishii; N Sakamoto
Journal:  Diabetes Care       Date:  2001-10       Impact factor: 19.112

6.  Structural and kinetic modifications of aldose reductase by S-nitrosothiols.

Authors:  S Srivastava; B L Dixit; K V Ramana; A Chandra; D Chandra; A Zacarias; J M Petrash; A Bhatnagar; S K Srivastava
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Selective recognition of glutathiolated aldehydes by aldose reductase.

Authors:  K V Ramana; B L Dixit; S Srivastava; G K Balendiran; S K Srivastava; A Bhatnagar
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

8.  The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.

Authors:  Federico Ruiz; Isabelle Hazemann; Andre Mitschler; Andrzejj Joachimiak; Thomas Schneider; Martin Karplus; Alberto Podjarny
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

9.  Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.

Authors:  E I Howard; R Sanishvili; R E Cachau; A Mitschler; B Chevrier; P Barth; V Lamour; M Van Zandt; E Sibley; C Bon; D Moras; T R Schneider; A Joachimiak; A Podjarny
Journal:  Proteins       Date:  2004-06-01

10.  Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.

Authors:  Ossama El-Kabbani; Connie Darmanin; Thomas R Schneider; Isabelle Hazemann; Federico Ruiz; Mitsuru Oka; Andrzejj Joachimiak; Clemens Schulze-Briese; Takashi Tomizaki; Andre Mitschler; Alberto Podjarny
Journal:  Proteins       Date:  2004-06-01
View more
  4 in total

1.  B-factor Analysis and Conformational Rearrangement of Aldose Reductase.

Authors:  Ganesaratnam K Balendiran; J Rajendran Pandian; Evin Drake; Anubhav Vinayak; Malkhey Verma; Duilio Cascio
Journal:  Curr Proteomics       Date:  2014       Impact factor: 0.837

2.  Path-integral method for predicting relative binding affinities of protein-ligand complexes.

Authors:  Chandrika Mulakala; Yiannis N Kaznessis
Journal:  J Am Chem Soc       Date:  2009-04-01       Impact factor: 15.419

Review 3.  Alpha-Lipoic Acid as a Nutritive Supplement for Humans and Animals: An Overview of Its Use in Dog Food.

Authors:  Reshma M Anthony; Jennifer M MacLeay; Kathy L Gross
Journal:  Animals (Basel)       Date:  2021-05-19       Impact factor: 2.752

4.  Effect of Oral Alpha Lipoic Acid in Preventing the Genesis of Canine Diabetic Cataract: A Preliminary Study.

Authors:  David L Williams
Journal:  Vet Sci       Date:  2017-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.